| Management protocol for abacavir-related hypersensitivity reaction. | |
| | |
MedLine Citation:
|
PMID: 10676833 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To develop an abacavir hypersensitivity reaction management protocol for the University of Oklahoma Health Sciences Center. DATA SYNTHESIS: Conference abstracts, published literature, and manufacturer-provided materials were reviewed to define the syndrome and manifestations and to recommend steps to take when a patient develops abacavir-related reactions. RESULTS: Initial education, formalized contact and response mechanism, and intervention levels were incorporated into a protocol for clinicians. CONCLUSIONS: Abacavir, a newly approved agent for the treatment of HIV, has been associated with a fatal hypersensitivity reaction. Our protocol provides a mechanism to minimize progression of abacavir hypersensitivity reaction by providing a formalized management procedure. |
| | |
Authors:
|
P G Clay; R C Rathbun; L N Slater |
Related Documents
:
|
15973593 - Parecoxib. pharmacia corp. 7748873 - Speech outcomes in adolescents with cleft lip and palate. 11039463 - Should nuclear medicine physicians give the results of radioisotope examinations direct... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The Annals of pharmacotherapy Volume: 34 ISSN: 1060-0280 ISO Abbreviation: Ann Pharmacother Publication Date: 2000 Feb |
Date Detail:
|
Created Date: 2000-03-08 Completed Date: 2000-03-08 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 9203131 Medline TA: Ann Pharmacother Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 247-9 Citation Subset: IM; X |
Affiliation:
|
Fellow of Infectious Diseases, College of Pharmacy, University of Oklahoma, Oklahoma City, USA. pclay@cctr.umkc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anti-HIV Agents
/
adverse effects*,
contraindications,
therapeutic use Dideoxynucleosides / adverse effects*, contraindications, therapeutic use Drug Hypersensitivity / therapy* HIV Infections / complications, drug therapy Humans |
| Chemical | |
Reg. No./Substance:
|
0/Anti-HIV Agents; 0/Dideoxynucleosides; 0/abacavir |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Anterior ocular infections: an overview of pathophysiology and treatment.
Next Document: The role of vasopressin in the treatment of vasodilation in shock states.